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Fig 1. Superficial partial-thickness thermal burns caused
by a forced-air warming device used on a patient who
underwent a procedure with general anesthesia (right
lower leg shown). Vesicles were tender with surrounding
erythema (3 to 6 mm in diameter), linearly and regularly
distributed (exactly 1 cm apart), on the inner medial aspect
of both lower legs.
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this patient with poor vascular circulation.
Hypoperfusion is a risk factor for thermal injuries
with the use of these devices, as cautioned in the
manufacturer’s guideline.5 This is also consistent
with other reported cases in which burns occurred
when FAW devices were used in patients with
congenital cyanotic heart disease or during pro-
cedures such as aortic clamping.2,4
Nonetheless, FAW devices are generally safe and
rare cases of thermal burns should not dissuade its
use. A blanket cover between the patient and
warming blanket to avoid direct contact may be
used as a preventive measure. Our patient was
instructed to keep his lower extremities elevated, to
apply Silvadene to the affected areas, and to not
debride or unroof the vesicles. The surgical team
was also reassured and informed of the adverse
effect caused by this FAW device. With these
recommendations, the patient experienced an un-
eventful, full recovery without any residual lesions or
scarring.
Eliciting the surgical history is key to the proper
diagnosis of FAW device thermal burns and it can
easily be misdiagnosed without this necessary infor-
mation. It is important for dermatologists to be aware
of this potential complication and its specific cuta-
neous findings.Open access under CC BY-NC-ND license.AKP would like to thank Elizabeth Huynh for her
editorial contribution.
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Reactive hemophagocytic syndrome in a
patient with adult-onset Still disease
To the Editor: A healthy 37-year-old woman pre-
sented with a 2-week history of fever, arthralgias
affecting knees and wrists, and an evanescent rash.
The rash presented every day and favored the
trunk, extremities, and face (Fig 1, A). Clinically,
she had erythematous macules and papules scat-
tered over her trunk, neck, and extremities, which
exhibited the Koebner phenomenon. There was no
evidence of pharyngitis, cervical lymphadenopa-
thy, hepatosplenomegaly, pleuritis, or pericarditis
on physical examination. Blood work was signifi-
cant for a white blood count (WBC) of 17.6
(normal: 3.5 to 10.5 3 109/L) with more than 80%
neutrophils, C-reactive protein was 167 (normal:
\10 mg/L), erythrocyte sedimentation rate was 71
(normal: 0 to 10 mm/hr), and ferritin was 4422
(normal: 11 to 307 g/L). An infectious workup
was noncontributory and an autoimmune screen
was negative.
Fig 1. Adult-onset Still disease. A, Evanescent salmon-
pink papules and macules on the upper extremity of a 37-
year-old woman with fever and arthralgias. B, Linear
patches on the thigh hours after scratching the skin,
demonstrating the Koebner phenomenon.
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and the patient was treated conservatively with
ibuprofen, in that she declined prednisone. Her
condition rapidly deteriorated, and she was admitted
to the intensive care unit with hypotension, dissem-
inated intravascular coagulation, and multiorgan
failure. She was treated with methylprednisolone
and intravenous immunoglobulin. As her status
declined, bone marrow biopsy and aspirate findings
were consistent with the suspected of diagnosis of
reactive hemophagocytic syndrome (RHS). She died
within days.
AOSD is an uncommon, poorly understood in-
flammatory process, characterized by 4 cardinal
symptoms: spiking fever $398C, arthralgias or
arthritis, evanescent rash, and elevated WBC
($10,000 cells/mm3) with 80% neutrophils or
more.1 Rash is present in 77% to 100% of cases and
is an important diagnostic clue.1 Classically, the rash
is asymptomatic and composed of evanescent
salmon-pink colored macules or papules, with
maximal intensity during fever spikes.1 The trunk
and extremities are most commonly involved; yet the
rash has a predilection for sites of pressure, such as
areas of tight clothing, which was exemplified in our
patient. Light trauma may trigger the rash, demon-
strating theKoebner phenomenon (Fig 1,B).2 Ferritin
is often significantly elevated, andmay correlate with
disease activity.2 Importantly, AOSD can culminate in
RHS in 12% to 15% of cases.3,4 RHS is a life-
threatening complication of rheumatic diseasescharacterized by fever, hepatosplenomegaly, pancy-
topenia, lymphadenopathy, rash, and increased pro-
liferation of benign histiocytes in the bone marrow.
High ferritin and liver function tests are often present.
RHSmay also develop in patientswith systemic lupus
erythematosus, lymphoma, or serious infections.3,4
There is limited literature on RHS, and although
there is evidence that early treatment of RHS may
improve prognosis,5 there is no specific data to
support or refute that early aggressive treatment in
AOSD would prevent development of RHS.
Intuitively, though, it follows that disease control
might bestow a more favorable outcome.
Interestingly, in 2 of the case series, RHS developed
in only 1 of 14 patients (combined) during AOSD
remission. Immunosuppressants were not routinely
used before the onset of RHS in either series (2 of 8
and 2 of 6).3,4 This suggests that RHSmay be less likely
to develop in patients with controlled AOSD. Taken
together, it is important to identify and monitor
patients with AOSD for potentially life-threatening
sequelae, so that prompt treatment is possible.
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